Free Float 68,25 %
Shares Float 30,72 M
Shares Outstanding 45,01 M
Cline Scientific AB (publ)
Share · SE0006758231 (XSTO)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Cline Scientific AB (publ)
No Price
Share Float & Liquidity
Company Profile for Cline Scientific AB (publ) Share
Cline Scientific AB (publ) develops cancer diagnostics and regenerative medicine treatments in Sweden. It develops an allogenic stem cell therapy based on induced pluripotent stem (iPS) cells. The company also develops surface nanotechnology for cell-based products and processes to drive projects within life science into the clinical phase. It has collaboration with AstraZeneca to utilize gradient technology. Cline Scientific AB (publ) was founded in 2012 and is based in Mölndal, Sweden.
Company Data
Name Cline Scientific AB (publ)
Company Cline Scientific AB (publ)
Website
https://www.clinescientific.com
Primary Exchange 
NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
ISIN SE0006758231
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Anders Patrik Sundh
Country Sweden
Currency SEK
Employees 0,0 T
Address Argongatan 2C, 431 53 Mölndal
IPO Date 2015-03-30
Stock Splits
| Date | Split |
|---|---|
| 16.06.2023 | 201:163 |
| 14.06.2021 | 103:100 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | CLINE-B.ST |
More Shares
Investors who hold Cline Scientific AB (publ) also have the following shares in their portfolio:
